Crossing from Analytical to Diagnostics

Opening

Almost every clinical measurement principle used in hospitals today originated in analytical science. The organisations that built the diagnostics industry were not the ones that developed those principles. They were the ones that understood what it takes to deploy them in a clinical setting.

Most analytical technologies never make that crossing — not because they lack performance, but because they are not built for the institutional conditions of clinical use. This monograph examines why the crossing fails so consistently despite clear economic attraction, and under what conditions it can succeed.

The central problem

Analytical systems are designed to maximise flexibility — broad application, rapid iteration, adaptable workflows. Clinical environments demand the opposite: constraint, standardisation, and manufacturer accountability for every result in every deployment.

This is not a compatibility problem that engineering can resolve. It is a structural gap between two different kinds of market, each with its own logic, its own capital requirements, and its own criteria for what constitutes a functioning product.

The crossing is not a product launch. It is a transformation from one type of system to another — complete, irreversible, and on the clinical market’s terms.

What this monograph examines

The crossing is structured around seven conditions across three phases that must be met simultaneously. None is sufficient alone. The monograph examines each condition, the interactions between them, and the consequences of attempting the crossing when any single condition is absent.

It covers:

• The structural gap between the analytical and diagnostics markets
• The capital asymmetry of the crossing and what it implies for timing and commitment
• Regulatory states as strategic positions, not compliance milestones
• Field observations from Analytica Munich 2026 across five technology domains
• Three detailed failure cases and one crossing that succeeded completely
• The conditions under which a crossing should not be attempted

Analytical basis

The monograph draws on the structural framework developed in Inside the Clinical Diagnostics Industry: Constraints Shaping Strategy — Towards Health Intelligence (Oliveira, 2026) and on field observation at Analytica Munich 2026. It is the first publication in the IVD Industry Monograph series — the primary analytical output of Persodia Research.

About the series

Each monograph in the IVD Industry Monograph series examines a single structural question at the intersection of industry organisation, clinical deployment, and market economics. The series is observational rather than prescriptive, cumulative rather than episodic. Each publication builds on the framework established in the book and extended by prior monographs.

Assumed knowledge

The monograph assumes familiarity with the diagnostics and analytical instruments industries. Readers without direct commercial or technical experience in either market will find the structural argument accessible but will benefit from prior reading of Inside the Clinical Diagnostics Industry.

Access

This monograph is available without charge. Access requires a brief declaration of context and purpose — the authors wish to understand who engages with the material and in what context. Full copyright is retained by the authors. The material may be read, cited, and discussed freely. It may not be reproduced or repurposed without prior written permission.